{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:31:22Z","timestamp":1791469882373,"version":"4.3.4"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1001\/jamadermatol.2018.0916","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T22:30:57Z","timestamp":1526596257000},"page":"796","source":"Crossref","is-referenced-by-count":24,"title":["Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis"],"prefix":"10.1001","volume":"154","author":[{"given":"Mathieu","family":"Jouvray","sequence":"first","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Launay","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Dubucquoi","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"Institut d\u2019Immunologie, CHU Lille, Institut d\u2019Immunologie, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sobanski","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Podevin","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lambert","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Morell-Dubois","sequence":"additional","affiliation":[{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maillard","sequence":"additional","affiliation":[{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Hatron","sequence":"additional","affiliation":[{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Giovannelli","sequence":"additional","affiliation":[{"name":"University Lille, Lille Inflammation Research International Center, Lille, France"},{"name":"Inserm, Lille, France"},{"name":"CHU Lille, D\u00e9partement De M\u00e9decine Interne et Immunologie Clinique, Lille, France"},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Autoimmunes et Syst\u00e9miques Rares du Nord et Nord-Ouest de France, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"doi180018r1"},{"issue":"5","key":"doi180018r2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma.","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"4","key":"doi180018r3","first-page":"195","article-title":"Pathogenesis of telangiectasia in scleroderma.","volume":"18","author":"Mould","year":"2000","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"doi180018r4","first-page":"7","article-title":"Clinical utility of telangiectasia of hands in scleroderma and other rheumatic disorders.","volume":"20","author":"Robert-Thomson","year":"2002","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"doi180018r5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3899\/jrheum.090697","article-title":"Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension.","volume":"37","author":"Shah","year":"2010","journal-title":"J Rheumatol"},{"issue":"7","key":"doi180018r6","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/acr.v68.7","article-title":"Skin telangiectasia and the identification of a subset of systemic sclerosis patients with severe vascular disease.","volume":"68","author":"Hurabielle","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"doi180018r7","first-page":"S106","article-title":"Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.","volume":"33","author":"Zhang","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"doi180018r8","first-page":"S92","article-title":"The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.","volume":"33","author":"Yalcinkaya","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"doi180018r9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/1523-1747.ep12522736","article-title":"Ultrastructure and three-dimensional reconstruction of several macular and papular telangiectases.","volume":"81","author":"Braverman","year":"1983","journal-title":"J Invest Dermatol"},{"issue":"7","key":"doi180018r10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"doi180018r11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.autrev.2011.04.019","article-title":"Angiogenic cytokines and growth factors in systemic sclerosis.","volume":"10","author":"Liakouli","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"12","key":"doi180018r12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor \u00df\u2014at the centre of systemic sclerosis.","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"doi180018r13","first-page":"275","article-title":"The TGF beta receptor endoglin in systemic sclerosis.","volume":"19","author":"Dharmapatni","year":"2001","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"doi180018r15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10103-013-1298-1","article-title":"Telangiectasis in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment.","volume":"29","author":"Halachmi","year":"2014","journal-title":"Lasers Med Sci"},{"issue":"1","key":"doi180018r16","doi-asserted-by":"publisher","first-page":"a006429","DOI":"10.1101\/cshperspect.a006429","article-title":"Endothelial cell heterogeneity.","volume":"2","author":"Aird","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"21","key":"doi180018r17","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/ajmg.a.v146a:21","article-title":"Genotype-phenotype relationship for localization and age distribution of telangiectases in hereditary hemorrhagic telangiectasia.","volume":"146A","author":"Letteboer","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"4","key":"doi180018r18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000360159","article-title":"Systemic sclerosis with normal or nonspecific nailfold capillaroscopy.","volume":"228","author":"Fichel","year":"2014","journal-title":"Dermatology"},{"key":"doi180018r19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mvr.2016.12.003","article-title":"Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.","volume":"111","author":"Pizzorni","year":"2017","journal-title":"Microvasc Res"},{"issue":"1","key":"doi180018r20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3899\/jrheum.120667","article-title":"Is vasculopathy associated with systemic sclerosis more severe in men?","volume":"40","author":"Panopoulos","year":"2013","journal-title":"J Rheumatol"},{"issue":"6","key":"doi180018r21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.5114\/reum.2015.57637","article-title":"Comparison of clinical and serological parameters in female and male patients with systemic sclerosis.","volume":"53","author":"Wielosz","year":"2015","journal-title":"Reumatologia"},{"issue":"2","key":"doi180018r22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/acr.22673","article-title":"Risk of pulmonary embolism and deep venous thrombosis in systemic sclerosis: a general population-based study.","volume":"68","author":"Schoenfeld","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"doi180018r23","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1093\/rheumatology\/keu133","article-title":"Systemic sclerosis increases the risks of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study.","volume":"53","author":"Chung","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"9812","key":"doi180018r24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden.","volume":"379","author":"Z\u00f6ller","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"doi180018r25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study.","volume":"9","author":"Ramagopalan","year":"2011","journal-title":"BMC Med"},{"issue":"5","key":"doi180018r26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1053\/sarh.2002.50011","article-title":"Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis.","volume":"32","author":"Cerinic","year":"2003","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"doi180018r27","first-page":"1031","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb Haemost"},{"issue":"4","key":"doi180018r28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1365-2141.1993.tb03145.x","article-title":"Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.","volume":"84","author":"Goodfield","year":"1993","journal-title":"Br J Haematol"},{"issue":"2","key":"doi180018r29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000093846","article-title":"A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease.","volume":"213","author":"Fujimoto","year":"2006","journal-title":"Dermatology"},{"issue":"2","key":"doi180018r30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2015.10.003","article-title":"Soluble endoglin, hypercholesterolemia and endothelial dysfunction.","volume":"243","author":"Rathouska","year":"2015","journal-title":"Atherosclerosis"},{"issue":"7","key":"doi180018r31","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","article-title":"Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.","volume":"47","author":"Wipff","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"doi180018r32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fgene.2015.00115","article-title":"Research on potential biomarkers in hereditary hemorrhagic telangiectasia.","volume":"6","author":"Botella","year":"2015","journal-title":"Front Genet"},{"key":"doi180018r33","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.placenta.2013.10.020","article-title":"The enigmatic role of endoglin in the placenta.","volume":"35","author":"Gregory","year":"2014","journal-title":"Placenta"},{"issue":"4","key":"doi180018r34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/rheumatology\/kel378","article-title":"Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension.","volume":"46","author":"Wipff","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"doi180018r35","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1158\/1078-0432.CCR-12-0098","article-title":"A phase I first-in-human study of TRC105 (anti-endoglin antibody) in patients with advanced cancer.","volume":"18","author":"Rosen","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"doi180018r36","first-page":"S46","article-title":"Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.","volume":"29","author":"Riccieri","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"doi180018r37","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar596","article-title":"Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.","volume":"4","author":"Distler","year":"2002","journal-title":"Arthritis Res"},{"issue":"11","key":"doi180018r38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nrc2505","article-title":"VEGF-A splicing: the key to anti-angiogenic therapeutics?","volume":"8","author":"Harper","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"doi180018r39","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ Res"},{"issue":"3","key":"doi180018r40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3899\/jrheum.090600","article-title":"Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors.","volume":"37","author":"Ingraham","year":"2010","journal-title":"J Rheumatol"},{"key":"doi180018r14","volume-title":"R. A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2008"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2681557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T22:48:38Z","timestamp":1531349318000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.0916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.0916","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,1]]}}}